A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE1, PHASE2

מצבים רפואיים

Advanced Solid Tumors · Genital Neoplasm, Female · Urogenital Neoplasms · Lung Neoplasm · Neoplasms by Site · Papillomavirus Infection · Epstein-Barr Virus Infections · Carcinoma · Neoplasms · Vulvar Neoplasms · Vulvar Diseases · Abdominal Neoplasm

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים
  • Loma Linda University Cancer Center, Loma Linda, California, United States

    Contact: Study coordinator (John Shin, MD) · johnshin@llu.edu
    Contact: Principal Investigator (John Shin, MD)
  • UC Davis Comprehensive Cancer Center, Sacramento, California, United States

    Contact: Study coordinator (Kenya Gomez) · keagomez@ucdavis.edu
    Contact: Principal Investigator (Tianhong Li, MD)
  • Sarah Cannon Research Institute at HealthONE, Denver, Colorado, United States

    Contact: Study coordinator (Julia Etchart) · Julia.Etchart@SarahCannon.com
    Contact: Principal Investigator (Jason Henry, MD)
  • AdventHealth Celebration, Celebration, Florida, United States

    Contact: Study coordinator (Guru Sonpavde, MD) · 407 303 2024
    Contact: Principal Investigator (Guru Sonpavde, MD)
  • University of Miami Sylvester Comprehensive Cancer Center, Miami, Florida, United States

    Contact: Study coordinator (Marijo Billusic, MD) · 307-243-1543
    Contact: Principal Investigator (Marijo Billusic, MD)
  • The University of Kansas Cancer Center, Kansas City, Kansas, United States

    Contact: Study coordinator (Weijing Sun, MD) · wsun2@kumc.edu
    Contact: Principal Investigator (Weijing Sun, MD)
  • National Institutes of Health, Bethesda, Maryland, United States

    Contact: Study coordinator (Victoria Jeffers) · victoria.jeffers@nih.gov · 240-858-3783
    Contact: Principal Investigator (James Gulley, MD, PhD)
  • Massachusetts General Hospital Cancer Center, Boston, Massachusetts, United States

    Contact: Study coordinator (Ryan Sullivan, MD) · (617) 643-3614
    Contact: Principal Investigator (Ryan Sullivan, MD)
  • Dana-Farber Cancer Institute, Boston, Massachusetts, United States

    Contact: Study coordinator (Joanne Charles) · 617-632-6571
    Contact: Principal Investigator (Ann Silk, MD)
  • Karmanos Cancer Institute, Detroit, Michigan, United States

    Contact: Study coordinator (Victoria LaBush) · 313-576-8411
    Contact: Principal Investigator (Wasif Saif, MD)
  • Memorial Sloan-Kettering Cancer Center, New York, New York, United States

    Contact: Study coordinator (Luisa Belfoiore) · belfiol@mskcc.org · (646) 888-4247
    Contact: Principal Investigator (Gopa Iyer, MD)
  • The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States

    Contact: Study coordinator (Kai He, MD) · 6143664139
    Contact: Principal Investigator (Kai He, MD)
  • University of Oklahoma Health Sciences, Stephenson Cancer Center, Oklahoma City, Oklahoma, United States

    Contact: Study coordinator (Amanda Anundson) · amanda-anundson-2@ouhsc.edu
    Contact: Principal Investigator (Abdul R Naqash, MD)
  • Sarah Cannon Research Institute Oncology Partners (SCRI-Nashville), Nashville, Tennessee, United States

    Contact: Study coordinator (Ethan Trull) · ethan.trull@scri.com
    Contact: Principal Investigator (Meredith Pelster, MD)
  • The University of Texas, MD Anderson Cancer Center, Houston, Texas, United States

    Contact: Study coordinator (Ming Sun) · MSun6@mdanderson.org
    Contact: Principal Investigator (Stephane Champiat, MD)
  • UT Health Mays Cancer Center, San Antonio, Texas, United States

    Contact: Study coordinator (Sheniell Granato) · granatos@uthscsa.edu · 210-450-1950
    Contact: Principal Investigator (Sukeshi Patel Arora, MD)
  • Fred Hutchinson Cancer Center, Seattle, Washington, United States

    Contact: Study coordinator (Ariana Dumenigo Jimenez) · adumenigoj@fredhutch.org
    Contact: Study coordinator (Joe Lograsso) · jlograss@fredhutch.org
    Contact: Principal Investigator (Diane Tseng, MD)
  • University of Wisconsin- Madison, Madison, Wisconsin, United States

    Contact: Study coordinator (Vincent Ma, MD) · vtma@medicine.wisc.edu
    Contact: Principal Investigator (Vincent Ma, MD)
  • Princess Margaret Cancer Centre, Toronto, Ontario, Canada

    Contact: Study coordinator (Lillian Siu, MD) · 416-946-2911
    Contact: Principal Investigator (Lillian Siu, MD)
  • Research Institute of McGill University Health Centre, Montreal, Quebec, Canada

    Contact: Study coordinator (Ramy Saleh, MD) · ramy.saleh@mcgill.ca
    Contact: Principal Investigator (Ramy Saleh, MD)
  • Hopsital Institut Curie, Paris, France, France

    Contact: Study coordinator (Lucas Frezouls) · lucas.frezouls@curie.fr
    Contact: Principal Investigator (Christophe Le Tourneau, MD, PhD)
  • Oncopole Claudius Regaud IUCT, Toulouse, France, France

    Contact: Study coordinator (Carlos Gomez-Roca, MD) · gomez-roca.carlos@iuct-oncopole.fr
    Contact: Principal Investigator (Carlos Gomez-Roca, MD)
  • Institut Bergonié, Bordeaux, France

    Contact: Study coordinator (Audrey Laroche-Clary) · +33 (0)5 56 33 04 33
    Contact: Principal Investigator (Antoine Italiano, MD)
  • Centre Leon Berard, Lyon, France

    Contact: Study coordinator (Severine Laurent) · severine.laurent@lyon.unicancer.fr
    Contact: Principal Investigator (Philippe Cassier, MD)
  • Institute Gustave Roussy, Villejuif, France

    Contact: Study coordinator (Romain Di-Vincenzo) · +33 1 42 11 58 31
    Contact: Principal Investigator (Aurelien Marabelle, MD)
  • Vall d'Hebron Institute of Oncology, Barcelona, Catalonia, Spain

    Contact: Study coordinator (Gemma Mur) · (+34) 932 54 34 50
    Contact: Principal Investigator (Elena Garralda, MD)
  • Clinica Universidad de Navarra, San Blas-Canillejas, Madrid, Spain

    Contact: Study coordinator (Eduardo Castañon, MD) · ecastanon@unav.es
    Contact: Principal Investigator (Eduardo Castanon, MD)
  • Hospital Universitario Quirónsalud Madrid, Madrid, Spain, Spain

    Contact: Study coordinator (Micaela Belén Acosta) · mbelen@nextoncology.eu · 919499716
    Contact: Principal Investigator (Valentina Boni, MD)
  • NEXT Oncology Barcelona, Hospital Quirónsalud Barcelona, Barcelona, Spain

    Contact: Study coordinator (Omar Saavedra, MD) · osaavedra@nextoncology.eu
    Contact: Principal Investigator (Omar Saavedra, MD)
  • START Madrid FJD, Madrid, Spain

    Contact: Study coordinator (Manuel Pedregal) · +34 91 550 48 00
    Contact: Principal Investigator (Manuel Pedregal, MD)
  • Clinica Universidad de Navarra, Pamplona, Spain

    Contact: Study coordinator (Eduardo Castañon, MD) · ecastanon@unav.es
    Contact: Principal Investigator (Eduardo Castanon, MD)
  • Instituto de Investigacion Sanitaria, INCLIVA, Valencia, Spain

    Contact: Study coordinator (Susanna Roselló, MD) · srosello@incliva.es
    Contact: Principal Investigator (Susana Roselló, MD)